.svg){kind=icon}
Medical cannabis dosing is rarely a matter of finding one standard number that works for everyone.
Two patients can use the same product, take the same amount of THC, and report very different experiences.
Differences in tolerance, age, medications, metabolism, administration route, previous cannabis exposure, and individual biology can all affect response.
That is why medical cannabis discussions frequently use the phrase:
Start low and go slow.
A more precise description is:
Begin conservatively, observe the response, and make gradual adjustments with appropriate medical guidance.
This process is known as dose titration.
For Florida medical cannabis patients, titration should occur within the patient's physician-directed treatment plan rather than by chasing a particular milligram number.
What Is Dose Titration?
Dose titration means gradually adjusting the amount of a medication or active compound according to response.
The goal is not simply to keep increasing the dose.
Instead, titration attempts to identify an amount that provides the intended benefit while limiting unwanted effects.
That means the eventual dose might be:
- Increased
- Maintained
- Reduced
- Divided across the day
- Changed to another formulation
The appropriate endpoint varies from patient to patient.
Why Cannabis Requires Individualized Dosing
Cannabis contains multiple pharmacologically active compounds.
THC and CBD receive the most attention, but products may also contain:
- CBG
- CBC
- CBN
- THCV
- Terpenes
- Other minor cannabinoids
More importantly, patients respond differently to these compounds.
Factors affecting response can include:
- Previous cannabis experience
- THC tolerance
- Body composition
- Liver metabolism
- Age
- Other medications
- Medical conditions
- Food intake
- Sleep
- Route of administration
This variability makes it difficult to predict one ideal dose from demographics alone.
THC Usually Requires More Caution
THC is the primary intoxicating cannabinoid in cannabis.
Increasing THC exposure can increase the likelihood of effects such as:
- Dizziness
- Drowsiness
- Anxiety
- Impaired coordination
- Memory changes
- Increased heart rate
- Altered perception
- Intoxication
These effects are often dose-related.
That is one reason published medical-cannabis consensus protocols frequently use relatively small initial THC quantities and make adjustments gradually.
The numbers used in research or expert protocols should not be interpreted as universal prescriptions.
A patient's qualified physician should guide treatment decisions.
CBD Requires Titration Too
CBD is generally non-intoxicating, but that does not mean dose is irrelevant.
CBD can cause adverse effects and interact with medications.
Potential issues may include:
- Drowsiness
- Gastrointestinal effects
- Changes in appetite
- Liver-enzyme changes
- Drug interactions
Research involving pharmaceutical CBD often uses doses much higher than the CBD quantities commonly found in dispensary products.
Patients should therefore avoid assuming that:
More CBD = more benefit.
CBD dosing should also be evaluated according to response and medical context.
Change One Variable at a Time
One of the most useful principles in titration is consistency.
Imagine a patient changes all of these at once:
- THC dose
- CBD ratio
- Product
- Administration route
- Time of day
If the experience changes, it becomes difficult to know why.
A more informative approach is to keep as many variables stable as possible while evaluating one adjustment.
For example, a patient and physician may keep:
- The same product
- The same administration route
- The same approximate time
while evaluating the response to a measured change in cannabinoid dose.
This makes tracking much more meaningful.
Why Oral Cannabis Requires Patience
Edibles, tablets, and swallowed tinctures create one of the biggest titration challenges.
Their effects are delayed.
After oral THC is consumed, absorption occurs through the gastrointestinal tract and the cannabinoid undergoes first-pass metabolism in the liver.
This can produce 11-hydroxy-THC, an active metabolite.
As a result:
- Onset is slower
- Effects may build gradually
- Duration can be longer
- Individual variability can be substantial
A common dosing mistake is taking additional THC because:
“I don't feel anything yet.”
The first dose may still be developing.
Adding another dose too early can produce a much stronger cumulative effect later.
Sublingual Products Behave Differently
Tinctures may be administered under the tongue or swallowed depending on the product instructions.
Sublingual or oromucosal administration may allow some cannabinoids to enter circulation through oral tissues.
Any portion that is swallowed behaves more like an oral dose.
This means timing can depend on:
- Formulation
- Application method
- How long it remains in the mouth
- Amount swallowed
Patients should follow the labeled instructions rather than assuming every tincture has the same onset.
Inhalation Has Faster Feedback
Inhaled cannabis generally produces effects much more quickly than oral products.
That faster feedback can make it easier to recognize immediate effects.
But inhalation creates another problem:
A puff is not a standardized milligram dose.
The amount delivered can vary according to:
- Puff duration
- Device power
- Product potency
- Airflow
- Inhalation depth
- Vaporizer design
This makes precise titration more difficult unless the device has validated dose-delivery characteristics.
Ratios Can Change During Titration
Titration does not always mean increasing THC alone.
A physician may consider the balance between cannabinoids.
Examples include:
- THC-dominant
- CBD-dominant
- Balanced THC
- Formulations containing minor cannabinoids
A 1:1 THC product behaves differently from a highly THC-dominant formulation.
But ratios still do not replace dose.
A:
1:1 product containing 2.5 mg + 2.5 mg
is very different from:
1:1 containing 20 mg + 20 mg.
Both ratio and absolute milligrams matter.
What Should Patients Track?
Titration becomes much more useful when the patient records outcomes.
A simple log might include:
ItemWhat to RecordProductExact product and batchRouteOral, sublingual, inhaled, etc.THCMilligrams or measured amountCBDMilligrams or measured amountTimeWhen administeredTarget symptomWhat was being monitoredBenefit0–10 or simple notesSide effectsAnxiety, sedation, dizziness, etc.DurationHow long effects lasted
The goal is not to create perfect scientific data.
The goal is to identify patterns.
When Increasing the Dose May Not Be the Answer
If the desired result is not occurring, it can be tempting to increase THC immediately.
But dose is only one variable.
The issue may involve:
- Incorrect timing
- Administration route
- Product formulation
- Cannabinoid ratio
- Medication interaction
- Inconsistent use
- A symptom cannabis is not adequately addressing
Increasing the dose without understanding the problem can simply increase side effects.
What Is the Lowest Effective Dose?
In medication management, clinicians often seek the lowest effective dose.
That generally means the smallest amount that provides sufficient benefit without unnecessary adverse effects.
With cannabis, the optimal amount is not necessarily the highest dose a patient can tolerate.
Higher THC exposure can eventually increase:
- Impairment
- Cognitive effects
- Anxiety
- Sedation
- Tolerance
A stable lower dose may sometimes be more useful than continued escalation.
Tolerance Can Complicate Titration
Repeated THC exposure can lead to tolerance.
A patient may notice that a dose produces less noticeable effect after repeated use.
Automatically increasing the dose can create a cycle of escalating exposure.
Changes in effectiveness should therefore be discussed with the treating physician rather than assuming more THC is always appropriate.
Medication Interactions Matter
Patients taking prescription medications should include cannabis in medication reviews.
Particular caution may be warranted with medications that affect:
- Sedation
- Blood pressure
- Blood clotting
- Seizure thresholds
- Liver metabolism
- Cognition
THC, CBD, and other cannabinoids may interact with medications in different ways.
Patients with complex medical conditions or multiple medications may require a more conservative titration strategy.
Green Dragon Florida Examples for Understanding Titration
These products illustrate how formulation affects dosing decisions.
They are educational examples—not individualized starting-dose recommendations.
Le Remedie Calm 1:1 THC Tincture
Le Remedie Calm 1:1 THC Tincture is a balanced liquid formulation.
Tinctures illustrate why patients should evaluate both the cannabinoid ratio and the measured volume used.
A liquid format can provide more dosing information than descriptions such as “one bite” or “one puff,” but patients should still follow the product instructions and physician guidance.
Green Dragon Key Lime Hybrid Fast-Acting Chews — Tampa
Green Dragon Key Lime Hybrid Fast-Acting Chews are currently listed as a 100 mg THC package.
Edibles demonstrate why patients should distinguish the amount in the full package from the amount in an individual serving.
They also illustrate why delayed onset should be considered before taking additional THC.
Le Remedie Fast Acting THC Tablets — Avon Park
Le Remedie Fast Acting THC Tablets contain 100 mg THC total across ten 10 mg units.
A measured tablet format can make it easier to document what was taken compared with an unmeasured inhalation.
However, a labeled unit is not automatically the appropriate dose for every patient.
Product availability and formulation details may change by Green Dragon Florida location.
The Green Dragon Takeaway
“Start low and go slow” is useful shorthand, but medical cannabis titration is more than simply beginning with a small dose.
A thoughtful titration process involves:
- Knowing the THC and CBD amount
- Understanding the route
- Allowing adequate time to observe effects
- Changing one variable at a time
- Recording benefits and side effects
- Avoiding unnecessary dose escalation
- Reviewing medications and health conditions
- Working within the physician-directed treatment plan
The objective is not to reach the highest dose.
It is to identify a reproducible dose and formulation that meets the patient's treatment goals with acceptable side effects.